
Conference Coverage
about 21 hours ago
Systemic Inflammation Tied to Worse Outcomes in CKD, AMILatest Content

Obesity as a Neurobiological Disease: Fatima Cody Stanford, MD, MPH

Systemic Inflammation Tied to Worse Outcomes in CKD, AMI

Health Equity & Access Weekly Roundup: May 1, 2026

AI in Oncology Practice: Innovation in the Delivery of Care Itself

Breast Cancer in Young Women: Rani Bansal, MD, Discusses Subtypes, Disparities, and the Importance of Self-Advocacy

Shorts










Podcasts
Center on Health Equity & Access
All News

The therapy receives FDA approval for Alzheimer disease agitation, backed by phase 3 data showing significant symptom reduction and delayed relapse vs placebo.

Experts at AXS26 laid out why advanced therapies are underutilized and what payers, providers, and manufacturers must do together to change that.

At NAACOS 2026, experts highlighted how real-world AI tools are improving care delivery, outcomes, and efficiency across the health care landscape.

Adopting more automated services could potentially reduce costs across the country as adoption remains stable nationwide.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The results show that semaglutide could be a novel treatment for patients with alcohol use disorder moving forward.

The new work requirements for Medicaid eligibility, included in the One Big Beautiful Bill Act, will officially be required in January 2027.

Progressive care management approaches can enable meaningful, patient-centric outcomes without assuming risk.

Education on colorectal cancer symptoms and screening can help to prevent advancing disease in a cancer that is seeing increased incidence in younger adults.

As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case agreements, apheresis costs and whether to pursue accreditation.






















